Community-Acquired Pneumonia and Risk of Cardiovascular Events in People Living With HIV.
AIDS
HIV
cardiovascular disease
community‐acquired pneumonia
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
pubmed:
24
11
2020
medline:
27
3
2021
entrez:
23
11
2020
Statut:
ppublish
Résumé
Background Hospitalization with community-acquired pneumonia (CAP) is associated with an increased risk of cardiovascular disease (CVD) events in patients uninfected with HIV. We evaluated whether people living with HIV (PLWH) have a higher risk of CVD or mortality than individuals uninfected with HIV following hospitalization with CAP. Methods and Results We analyzed data from the Veterans Aging Cohort Study on US veterans admitted with their first episode of CAP from April 2003 through December 2014. We used Cox regression analyses to determine whether HIV status was associated with incident CVD events and mortality from date of admission through 30 days after discharge (30-day mortality), adjusting for known CVD risk factors. We included 4384 patients (67% [n=2951] PLWH). PLWH admitted with CAP were younger, had less severe CAP, and had fewer CVD risk factors than patients with CAP who were uninfected with HIV. In multivariable-adjusted analyses, CVD risk was similar in PLWH compared with HIV-uninfected (hazard ratio [HR], 0.89; 95% CI, 0.70-1.12), but HIV infection was associated with higher mortality risk (HR, 1.49; 95% CI, 1.16-1.90). In models stratified by HIV status, CAP severity was significantly associated with incident CVD and 30-day mortality in PLWH and patients uninfected with HIV. Conclusions In this study, the risk of CVD events during or after hospitalization for CAP was similar in PLWH and patients uninfected with HIV, after adjusting for known CVD risk factors and CAP severity. HIV infection, however, was associated with increased 30-day mortality after CAP hospitalization in multivariable-adjusted models. PLWH should be included in future studies evaluating mechanisms and prevention of CVD events after CAP.
Identifiants
pubmed: 33222591
doi: 10.1161/JAHA.120.017645
pmc: PMC7763776
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e017645Subventions
Organisme : NIAAA NIH HHS
ID : U01 AA020790
Pays : United States
Organisme : NIAAA NIH HHS
ID : U24 AA022001
Pays : United States
Organisme : NIAAA NIH HHS
ID : U24 AA020794
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL087713
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL142103
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI050409
Pays : United States
Organisme : NHLBI NIH HHS
ID : RC1 HL100347
Pays : United States
Organisme : NIAAA NIH HHS
ID : U10 AA013566
Pays : United States
Organisme : NHLBI NIH HHS
ID : K01 HL134147
Pays : United States
Références
J Infect. 2016 Aug;73(2):107-14
pubmed: 27288596
Medicine (Baltimore). 2009 May;88(3):154-9
pubmed: 19440118
Med Care. 2006 Aug;44(8 Suppl 2):S13-24
pubmed: 16849964
Clin Infect Dis. 2008 Jul 15;47(2):182-7
pubmed: 18533841
J Am Heart Assoc. 2018 Apr 21;7(9):
pubmed: 29680825
JAMA. 2015 Jan 20;313(3):264-74
pubmed: 25602997
Int J Infect Dis. 2013 Dec;17(12):e1125-9
pubmed: 24007923
N Engl J Med. 2018 Jan 25;378(4):345-353
pubmed: 29365305
JAMA Intern Med. 2013 Apr 22;173(8):614-22
pubmed: 23459863
Circulation. 2018 Jul 17;138(3):255-265
pubmed: 29535090
Nicotine Tob Res. 2011 Dec;13(12):1233-9
pubmed: 21911825
BMC Infect Dis. 2019 Apr 11;19(1):319
pubmed: 30975092
Am J Respir Crit Care Med. 2008 Jun 1;177(11):1242-7
pubmed: 18369199
Clin Infect Dis. 2007 Jul 15;45(2):158-65
pubmed: 17578773
Clin Infect Dis. 2005 Aug 15;41(4):554-6
pubmed: 16028168
Chest. 2017 Aug;152(2):295-303
pubmed: 28302496
Int J Infect Dis. 2010 Jan;14(1):e22-7
pubmed: 19586789
N Engl J Med. 2019 Jan 10;380(2):171-176
pubmed: 30625066
Tex Heart Inst J. 2007;34(1):11-8
pubmed: 17420787
Am J Med. 2011 Mar;124(3):244-51
pubmed: 21396508
Circulation. 2012 Feb 14;125(6):773-81
pubmed: 22219349
Am J Respir Crit Care Med. 2011 Feb 1;183(3):388-95
pubmed: 20851926
Med Care. 2006 Aug;44(8 Suppl 2):S25-30
pubmed: 16849965
Med Care. 2006 Aug;44(8 Suppl 2):S44-51
pubmed: 16849968
JAMA. 2012 Jul 25;308(4):405-6
pubmed: 22820794
PLoS One. 2014 Jan 02;9(1):e84285
pubmed: 24392121
J Am Coll Cardiol. 2015 Nov 17;66(20):2173-2184
pubmed: 26564594
J Am Heart Assoc. 2018 May 2;7(10):
pubmed: 29720501
PLoS One. 2009 Sep 14;4(9):e7022
pubmed: 19750011
PLoS Pathog. 2014 Sep 18;10(9):e1004383
pubmed: 25232870
Clin Infect Dis. 2012 Oct;55(7):996-1003
pubmed: 22715173
J Am Heart Assoc. 2020 Dec;9(23):e017645
pubmed: 33222591
HIV Med. 2015 Aug;16(7):421-30
pubmed: 25959543
PLoS One. 2015 Jul 20;10(7):e0132259
pubmed: 26193668
JAMA Cardiol. 2017 May 1;2(5):536-546
pubmed: 28384660
Am J Respir Crit Care Med. 2014 May 15;189(10):1173-80
pubmed: 24707986
Expert Opin Drug Saf. 2015 Feb;14(2):295-303
pubmed: 25494485
Eur Respir J. 2014 Jun;43(6):1698-708
pubmed: 24525448
Clin Infect Dis. 2017 Jun 1;64(11):1486-1493
pubmed: 28205683